Gum graft showdown: synthetic vs. natural tissue in recession repair
NCT ID NCT04800250
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a synthetic gum graft (Mucogain matrix) could be a good alternative to the standard connective tissue graft for treating receding gums. The goal was to see if the synthetic option covers the exposed tooth root just as well, but with less pain and fewer complications. The study planned to include 8 non-smoking adults with specific types of gum recession, but it was terminated early.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
8 people
The number who actually took part.
- Started
-
Jul 2023
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Patient with 3 contiguous, symmetrical and bilateral RTI Cairo gingival recessions (Miller Class 1) (i.e. 6 recessions) * Patient non-smoker * Patient affiliated to social security * Patient signed informed consent. Exclusion criteria: * Patient with or having presented an acute or chronic severe cardiovascular, kidney, liver, gastrointestinal, allergic, endocrine, neuropsychiatric pathology, developed cancer of the upper aero digestive tract treated with radiotherapy * Patient with severe hemorrhinopathy * Patient treated with oral retinoids, bisphosphonates, oral or anticonvulsants * Patient who has taken steroidal or non-steroidal anti-inflammatory therapy, anti-cancer or immunosuppressive chemotherapy within the last 6 months. * Patient with contraindication to necessary and pre-, per- or post-operative treatments * Follow-up of the patient seemed difficult by the investigator * Patient with insufficient oral hygiene incompatible with oral surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gingival recession are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
Nice, Provence-Alpes-Côte d'Azur Region, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gum graft surgery: does the bed matter for thin gums?
- Boosting gum grafts: do blood or gel Add-Ons reduce shrinkage?
- Can a new flap technique better cover receding gums?
- A new twist on gum surgery could better cover exposed roots
- Gum graft boost: growth factors may strengthen receding gum repair
- Micro-needling vs. gum graft: a tiny trial tests a simpler fix for receding gums